Another Superb Trading Week on the Books

Options Review – Thursday’s Three-for-Three:

We have been enjoying an impeccable success rate on our recent options interests, and we kept the train rolling in our premarket report yesterday morning with a group of ideas that yielded some pretty solid intraday gains.

We had a bullish target in the TWLO chain, and bearish targets in the BIDU and WMT chains, and in every case, we witnessed single-session runs of a significant nature. Here were the trading ranges and total possible profits associated with them:

 TWLO Weekly $445-460 Calls
$445:
 3.25-7.46 (+129%)
$450: 1.86-5.00 (+169%)
$455: 1.20-3.07 (+156%)
$460: .73-1.84 (+152%)
______

BIDU Weekly $305-290 Puts
$305: 11.26-17.90 (+59%)
$300: 7.85-13.50 (+72%)
$295: 5.29-9.60 (+81%)
$290: 3.28-7.15 (+118%)
______

WMT Weekly $143-140 Puts 

$143: 3.35-4.96 (+48%)
$142: 2.30-4.50 (+96%)
$141: 1.79-3.45 (+93%)
$140: 1.00-2.65 (+165%)


Fresh Options Ideas*: 
AMAT Weekly $117-120 Calls
DE Weekly $312.50-320 Calls
SPY Weekly $392-393 Calls 

*Please do not attempt to trade weekly options on a Friday unless you are an advanced level trader with access to disposable funds! 


Extended Watchlist: 
MJLB, HVBTF, BFARF, TGGI, SANP, KRKNF, BYOC, TMXN, RBNW, 

More Multi-bag Options Runners

CURE Pharmaceutical Holding Corp. CURR

We find CURR very interesting because of the company’s unique systems/methods for delivering drugs into the human body. It’s not often that we run into an OTC traded play with intriguing proprietary technologies.

The Company’s efforts to further position itself as an integrated healthcare company with its recent acquisition of The Sera Labs, a high-margin, multi-channel marketing and branding company with accelerating sales of its more than 20 products in the health & wellness, beauty, and pets categories and strong traction in both e-commerce and wholesale-to-retail distribution with total retail doors exceeding 8,850 in the U.S. to date. CURE acquired 100 percent of privately held The Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition.

The Sera Labs newest consumer product that uses CURE’s patented and advanced oral thin film strip technology under the trademark name Nutri-Strips with RAD3 (Rapid Activation Delivery) to deliver novel vitamins and supplements to consumers across the nation.

The Company’s future plans and focus on research and development into CURE’s pharmaceutical programs and The Sera Labs commitment to innovating its offerings with a “tele-wellness” program and exciting new products.

In addition to an interesting backstory the CURR chart itself looks rather attractive at the moment. The stock has just bounced off of its 52-week low, with a recent increase in volume. The PPS over the last two sessions has held a higher low, so we’ll be looking for the further establishment of higher highs and higher lows off of its bottom. Key resistance points to note are the 50DMA at 1.22 and the 200DMA at 1.73. We are definitely going to put this play on our watchlist this today and continue to track its progress going forward.


Options Recaps

We had a clean sweep on options in yesterday’s report, with each of the three sets of ideas we offered up to our readers performed quite well on the day. Here are the ranges and total potential intraday gains that were on the table:

DLTR Weekly $104-106 Calls
$104
: 2.38-8.11 (+241%)
$105: 1.94-6.94 (+258%)
$106: 1.03-6.45 (+526%)
_____

AMBA Weekly $68.50-70 Calls
$68.50
: 3.28-6.50 (+98%)
$69: 2.20-7.20 (+227%)
$70: 1.55-6.39 (+312%)
_____

NTNX Weekly $30-32 Calls 
$30: .50-1.11 (+222%)
$31: .24-.60 (+250%)
$32: .05-.30 (+500%)


Fresh Options Ideas: 
JWN Weekly $24-26 Calls*
DE Weekly $265-270 Calls*
GAP Weekly $24.50-23.50 Puts*

*Please note that these weekly contracts will expire early on Friday at the 1PM close, following tomorrow’s holiday. We hope everyone has a safe and happy Thanksgiving!


Extended Watchlist:
ENZC, TSNP, HYSR, MGTI

Winning Options Roundup

Reviewing Friday’s Winning Calls 

Our first order of business before kicking off this fresh trading week, is to go over the pwerformances of our options targets from Friday. We took a stab at three separate chains, with the BKE Weekly $17.50 Calls, the FL Weekly $27.50-28.50 Calls, and the DE Weekly $192.50-197.50 Calls.

With the exception of the BKE $15’s which didn’t pop, all but one of the contracts in our designated ranges recorded multibag moves on the day. Here are the total moves and possible gains that were available to us:

BKE Weekly $15-17.50 Calls
$17.50: 1.14-4.00 (+251%)
____

FL Weekly $27.50-28.50 Calls
$27.50:
 .26-.54 (+108%)
$28:  .08-.26 (+225%)
$28.50: .09-.15 (+67%)
____

DE Weekly $192.50-197.50 Calls
$192.50: 4.10-10.41 (+154%)
$195: 2.50-7.95 (+218%)
$197.50: 1.15-5.51 (+379%)
_____

Fresh Options Idea:
SPY 08/24 $341-342 Calls


Rising Biosciences, Inc. RBII

We have been tracking RBII quite a bit over the several weeks, having first tagged it on July 17th and following up with multiple mentions since then. The stock has made one heck of a move for us in that time.

From its low on July 17th of .002, the stock has absolutely ripped its way to a high of .029. That’s a remarkable move of 1350% in the a span of little more than a month. It’s gapping up over .03 this morning here in the premarket, so we expect that figure to be increased.


Extended Watchlist:
DSGT, LCDX, SHMP, HYBE, LCLP, MGON, VMNT